سعر اوجيسيتاميد 250مجم 20 اكياس 2026

Augicetamide 250 mg sachets, pack of 20 (AUG Pharma, Egypt): paracetamol 250 mg per sachet, an oral analgesic and antipyretic presented as granules in sachets.

• Symptomatic treatment of mild to moderate pain and/or feverPopulation: Children 4-12 years (17 kg and above) and adultsHealth Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)
• Temporary relief of minor aches and pains (sore throat, headache, cold/flu, muscular aches, backache, minor arthritis pain) and to reduce feverPopulation: Adults and children 12 years and over (US OTC product)DailyMed (US National Library of Medicine)

• Rare: anaemia, bone marrow depression, thrombocytopenia, oedema, pancreatitis, pruritus, rash, sweating, purpura, angioedema, urticaria, nephropathies and tubular disorders; very rare: serious skin reactions. Adverse reactions are rare and generally associated with overdose.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)

• Hypersensitivity to paracetamol or to any of the excipients; severe hepatic dysfunction (Child-Pugh >9).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)

• Do not take with other paracetamol-containing products (overdose risk). Use with caution in hepatocellular insufficiency, chronic alcohol abuse, severe renal insufficiency, Gilbert's syndrome, acute hepatitis, concomitant hepatotoxic drugs or enzyme inducers, glucose-6-phosphate dehydrogenase deficiency, haemolytic anaemia, dehydration and chronic malnutrition; avoid alcohol.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)
• Prolonged or frequent use and high doses: medication-overuse headache and analgesic nephropathy (risk of renal failure) may occur; consult a physician if high fever, signs of secondary infection occur or symptoms persist beyond 3 days.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)
• Contains sorbitol (600 mg sorbitol (E420) and 0.1 mg sucrose per sachet); patients with rare hereditary fructose intolerance should not take this medicine (Irish product; Egyptian excipients not verified).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)

• ProbenecidAlmost halves paracetamol clearance by inhibiting its conjugation; consider reducing the paracetamol dose.Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)
• Enzyme inducers (rifampicin, carbamazepine, phenytoin, phenobarbital, primidone) and alcoholMay increase hepatotoxicity of paracetamol through increased formation of the toxic metabolite; use with caution.Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)
• ZidovudineConcomitant use increases the tendency to neutropenia; use only on medical advice.Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)

• Epidemiological data with oral therapeutic doses indicate no undesirable effects on pregnancy or on the fetus/newborn, and prospective data after overdose showed no increase in malformation risk; under normal conditions of use paracetamol can be used throughout pregnancy after a benefit-risk assessment, but should not be taken for long periods, at high doses or in combination with other medicines, as safety in such cases is not established.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)
• Excreted into breast milk in small quantities with no undesirable effects reported in nursing infants; therapeutic doses may be used during breast-feeding.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland - copy hosted by Ethiopian Food and Drug Authority (EFDA)

• Paracetamol: Analgesic and antipyretic; the precise mechanism is not fully established and is thought to be mainly central (ingredient-level, shared cache).